← All US exec pay

Vertex Pharmaceuticals Inc / Ma (VRTX)

CEO compensation · Health Care · Biotechnology · FY2025
CEO total comp
$21.14M
Sector percentile
88.4th
Sector median
$7.11M
CEO pay ratio
—

Versus Health Care peers

Reshma Kewalramani's FY2025 total of $21.14M ranks at the 88.4th percentile among 174 sector CEOs · sector median $7.11M · p75 $15.12M.

CEO pay mix

CEO total comp over time

Named Executive Officers — FY2025

ExecutiveTitleSalaryBonusStockOptionIncentiveOtherTotalSource
Reshma Kewalramani CEO and President $1.60M—$15.00M —$4.12M$0.42M $21.14M SEC ↗
Stuart A. Arbuckle Former EVP & Chief Operating Officer $0.52M—$9.34M ——$0.13M $10.00M SEC ↗
Charles F. Wagner, Jr EVP & Chief Operating and Financial Officer $0.97M—$5.25M —$1.97M$0.05M $8.24M SEC ↗
Nia Tatsis EVP & Chief Regulatory and Quality Officer $0.75M—$4.90M —$1.28M$0.04M $6.97M SEC ↗
Amit Sachdev EVP & Chief Patient and External Affairs Officer $0.70M—$4.90M —$1.16M$0.02M $6.78M SEC ↗
Carmen Bozic EVP & Chief Medical Officer $0.83M—$4.38M —$1.38M$0.06M $6.65M SEC ↗

Every figure links to its source SEC proxy (DEF 14A). Extraction: edgar-html+claude-haiku.